KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health (CVS) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with -$840.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$840.0 million, compared with a TTM value of $116.0 million through Dec 2024, down 95.96%, and an annual FY2023 reading of $152.0 million, down 94.0% over the prior year.
  • Asset Writedowns and Impairment was -$840.0 million for Q4 2024 at Cvs Health, down from $607.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.5 billion in Q3 2022 and bottomed at -$840.0 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 3 years is $527.4 million, with a median of $349.0 million recorded in 2023.
  • Peak annual rise in Asset Writedowns and Impairment hit 751.22% in 2023, while the deepest fall reached 751.22% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $2.5 billion in 2022, then tumbled by 85.93% to $349.0 million in 2023, then plummeted by 340.69% to -$840.0 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for CVS at -$840.0 million in Q4 2024, $607.0 million in Q3 2024, and $349.0 million in Q1 2023.